Clinical Trials · NCT00943501
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 21
- Start date
- Nov 2009
- Locations
- 20 sites, 4 countries
- Primary endpoint
- Number and type of adverse events